Pharmacogenetics in drug development

被引：0
|
作者：
Becquemont, L. [1 ,2 ]
机构：
[1] Univ Paris Sud, Fac Med Paris Sud, F-94275 Le Kremlin Bicetre, France
[2] Hop Bicetre, Unite Rech Clin, Le Kremlin Bicetre, France
来源：
CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION | 2011年 / 15卷 / 05期
关键词：
Pharmacogenetics; Drug development; Biomarker; Target population; Adverse drug reaction; Polymorphisms; ANTICOAGULATION;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：156 / 160
页数：5
相关论文
共 50 条
  • [1] Pharmacogenetics and drug development
    Reiser, H
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 40, 2005, 40 : 417 - 427
  • [2] PHARMACOGENETICS AND DRUG DEVELOPMENT
    Beaune, P.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 4 - 5
  • [3] Pharmacogenetics in drug development
    McCarthy, AD
    Kennedy, JL
    Middleton, LT
    [J]. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2005, 360 (1460) : 1579 - 1588
  • [4] Applying pharmacogenetics in drug development
    Roses, AD
    [J]. DRUG DEVELOPMENT RESEARCH, 2004, 62 (02) : 79 - 80
  • [5] Pharmacogenetics in drug development and pharmacovigilance
    Roses, A. D.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 33 - 33
  • [6] Applications of pharmacogenetics in drug therapy and drug development
    Kirchheiner, J
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (09) : 691 - 692
  • [7] Pipeline Pharmacogenetics: A Novel Approach to Integrating Pharmacogenetics into Drug Development
    Akkari, P. Anthony
    Swanson, Thomas W.
    Crenshaw, Donna G.
    Grossman, Iris
    Sundseth, Scott
    Burns, Daniel K.
    Roses, Allen D.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (32) : 3754 - 3763
  • [8] Challenges and opportunities of pharmacogenetics in drug development
    March, Ruth
    [J]. PERSONALIZED MEDICINE, 2006, 3 (02) : 195 - 206
  • [9] Pharmacogenetics and future drug development and delivery
    Roses, AD
    [J]. LANCET, 2000, 355 (9212): : 1358 - 1361
  • [10] Pharmacogenetics in drug development: Regulatory and clinical considerations
    Hall, ST
    Abbott, N
    Schmith, G
    Brazell, C
    [J]. DRUG DEVELOPMENT RESEARCH, 2004, 62 (02) : 102 - 111
12345